scholarly article | Q13442814 |
P356 | DOI | 10.1002/J.1460-2075.1992.TB05140.X |
P953 | full work available at URL | https://europepmc.org/articles/PMC556542 |
https://europepmc.org/articles/PMC556542?pdf=render | ||
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1347744/?tool=EBI | ||
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1347744/pdf/?tool=EBI | ||
P932 | PMC publication ID | 556542 |
P698 | PubMed publication ID | 1347744 |
P2093 | author name string | A. Baniahmad | |
R. Renkawitz | |||
A. C. Köhne | |||
P2860 | cites work | Mutations that alter both localization and production of a yeast nuclear protein | Q61631665 |
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
The steroid and thyroid hormone receptor superfamily | Q27861095 | ||
Identification of a receptor for the morphogen retinoic acid | Q28280559 | ||
The c-erb-A protein is a high-affinity receptor for thyroid hormone | Q28282719 | ||
The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors | Q28297907 | ||
Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence | Q29547917 | ||
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors | Q29615768 | ||
How eukaryotic transcriptional activators work | Q29618289 | ||
v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene | Q34553519 | ||
v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. | Q35000459 | ||
Ecdysterone regulatory elements function as both transcriptional activators and repressors | Q36687580 | ||
c-erbA encodes multiple proteins in chicken erythroid cells | Q36846588 | ||
Genetic dissection of functional domains within the avian erythroblastosis virus v-erbA oncogene | Q36847673 | ||
Transcriptional repression in eukaryotes | Q37941786 | ||
Multiple cell type-specific proteins differentially regulate target sequence recognition by the alpha retinoic acid receptor | Q38338308 | ||
Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site | Q38340913 | ||
Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor | Q38341530 | ||
Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression | Q38341818 | ||
Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer | Q38343050 | ||
Transcriptional repression of eukaryotic promoters | Q38365817 | ||
Nuclear receptors enhance our understanding of transcription regulation | Q39324380 | ||
Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation | Q40136598 | ||
New Procedure for DNA Transfection with Polycation and Dimethyl Sulfoxide | Q40675293 | ||
Active repression of transcription by the engrailed homeodomain protein | Q41080980 | ||
Characterization of the hormone-binding domain of the chicken c-erbA/thyroid hormone receptor protein | Q41090648 | ||
A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors | Q41274369 | ||
A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes | Q41333116 | ||
Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements | Q41347641 | ||
Depletion of L-3,5,3'-Triiodothyronine and L-Thyroxine in Euthyroid Calf Serum for Use in Cell Culture Studies of the Action of Thyroid Hormone* | Q41621030 | ||
Regulation of progesterone receptor-mediated transcription by phosphorylation | Q41710148 | ||
Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor | Q42494510 | ||
The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements | Q43679715 | ||
An amino-terminal fragment of GAL4 binds DNA as a dimer | Q44240938 | ||
Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist | Q44537287 | ||
Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity | Q45217737 | ||
Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. | Q45953874 | ||
Retinoic acid and thyroid hormone induce gene expression through a common responsive element. | Q46001994 | ||
A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1. | Q46963035 | ||
Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system | Q48205412 | ||
Proliferation and differentiation of embryonic chick sympathetic neurons: effects of ciliary neurotrophic factor. | Q52247249 | ||
Developmental regulation of beta-globin gene switching. | Q52249886 | ||
Drosophila Krüppel protein is a transcriptional repressor. | Q52449047 | ||
A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. | Q54713263 | ||
Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product | Q59098062 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tretinoin | Q29417 |
P304 | page(s) | 1015-23 | |
P577 | publication date | 1992-03-01 | |
P1433 | published in | The EMBO Journal | Q1278554 |
P1476 | title | A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor | |
P478 | volume | 11 |
Q40017010 | A Domain of the even-skipped Protein Represses Transcription by Preventing TFIID Binding to a Promoter: Repression by Cooperative Blocking |
Q39663814 | A Novel Cytoplasmic Adaptor for Retinoic Acid Receptor (RAR) and Thyroid Receptor Functions as a Derepressor of RAR in the Absence of Retinoic Acid* |
Q36573257 | A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release |
Q36686878 | A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). |
Q33844628 | A highly selective, label-free, homogenous luminescent switch-on probe for the detection of nanomolar transcription factor NF-kappaB. |
Q39447809 | A novel role for helix 12 of retinoid X receptor in regulating repression |
Q38352823 | A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. |
Q35686843 | A regulatory system for use in gene transfer |
Q39471038 | A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor |
Q36556770 | A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha |
Q24683893 | Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu |
Q36560941 | Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states |
Q24554508 | Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily |
Q36570703 | Both thyroid hormone and 9-cis retinoic acid receptors are required to efficiently mediate the effects of thyroid hormone on embryonic development and specific gene regulation in Xenopus laevis |
Q40396342 | COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells |
Q37376082 | CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription |
Q34166628 | CTCF is conserved from Drosophila to humans and confers enhancer blocking of the Fab-8 insulator |
Q36078330 | Characterization of downstream elements in a Raf-1 pathway |
Q40792409 | Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor |
Q24648169 | Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex |
Q36574046 | Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression |
Q40015630 | Core promoter elements and TAFs contribute to the diversity of transcriptional activation in vertebrates |
Q35563843 | DAX1 and its network partners: exploring complexity in development |
Q33886757 | Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation |
Q40023991 | Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression |
Q35875001 | Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor |
Q38309584 | Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha |
Q33888108 | Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. |
Q24514479 | Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation |
Q24313680 | ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation |
Q40016745 | Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer |
Q24533137 | Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter |
Q40873357 | Functional domains of the Drosophila Engrailed protein |
Q40023148 | Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression |
Q36664756 | Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor |
Q36211947 | Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants |
Q40480355 | Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. |
Q37175215 | Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties |
Q36666829 | Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha |
Q36556508 | Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone |
Q24533537 | Involvement of negative cofactor NC2 in active repression by zinc finger-homeodomain transcription factor AREB6 |
Q37290828 | Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses |
Q42663412 | Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. |
Q24313231 | Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex |
Q37337779 | Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding |
Q78252318 | Ligand-free RAR can interact with the RNA polymerase II subunit hsRPB7 and repress transcription |
Q36655046 | Mapping and mutagenesis of the amino-terminal transcriptional repression domain of the Drosophila Krüppel protein |
Q38358466 | Molecular mechanisms of COUP-TF-mediated transcriptional repression: evidence for transrepression and active repression |
Q36566667 | Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region |
Q37251354 | Multiple mutations contribute to repression by the v-Erb A oncoprotein |
Q39723148 | Multiple receptor interaction domains of GRIP1 function in synergy |
Q41036772 | Multiple steps in the regulation of transcription-factor level and activity |
Q36570551 | Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity. |
Q40021079 | Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. |
Q40800435 | Negative regulation of transcription in eukaryotes |
Q28367742 | New retinoid X receptor subtypes in zebra fish (Danio rerio) differentially modulate transcription and do not bind 9-cis retinoic acid |
Q34448240 | Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation |
Q35202493 | Proteasomal regulation of nuclear receptor corepressor-mediated repression |
Q24548135 | Protein-protein interaction between the transcriptional repressor E4BP4 and the TBP-binding protein Dr1 |
Q36569110 | Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor |
Q36760762 | Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region |
Q37241518 | Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha |
Q36813375 | SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers |
Q22009109 | SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor |
Q33716064 | Specific mutations in the ligand binding domain selectively abolish the silencing function of human thyroid hormone receptor beta |
Q24684065 | Steroid receptor induction of gene transcription: a two-step model |
Q40020247 | The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal |
Q40017152 | The Transcriptional Repressor Even-skipped Interacts Directly with TATA-Binding Protein |
Q38321491 | The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription |
Q42508346 | The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation |
Q38354882 | The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K. |
Q36822461 | The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms |
Q37229683 | The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor |
Q40015924 | The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation |
Q36675733 | The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3. |
Q36554302 | The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat |
Q28263578 | The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor |
Q24646988 | The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing |
Q34569982 | Thyroid hormone and leptin in the testis. |
Q33295447 | Thyroid hormone receptor orthologues from invertebrate species with emphasis on Schistosoma mansoni |
Q41119685 | Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors |
Q58748789 | Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor-4 |
Q34294723 | Transcription factors as drug targets: opportunities for therapeutic selectivity. |
Q34748840 | Transcriptional activation by the orphan nuclear receptor ARP-1. |
Q37241513 | Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex |
Q34610377 | Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR. |
Q33779119 | Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. |
Q34798810 | Transcriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain |
Q39465831 | Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor |
Q33780043 | Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors |
Q24543959 | Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors |
Q40231308 | Two silencing sub-domains of v-erbA synergize with each other, but not with RXR. |
Q24310721 | Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression |
Q39454178 | tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau4 activation function and full dissociation of corepressors |
Search more.